Drug intelligence / Profile preview

Cynarix

Development stage
Unknown
Lead developer
Montavit
Modality
Small Molecules
Administration
Oral
01

Overview

Cynarix is a traditional herbal medicinal product developed and manufactured by Pharmazeutische Fabrik Montavit GmbH. Its active ingredient is a standardized dry extract of artichoke leaves (*Cynara scolymus*), which is rich in caffeoylquinic acids such as chlorogenic acid. The drug is primarily indicated for the relief of digestive system disorders, including symptoms of dyspepsia such as bloating, nausea, flatulence, and sensations of fullness. Its primary mechanism of action involves a choleretic effect, which increases the flow of bile to facilitate the digestion of fats, particularly after heavy meals. Cynarix is available in oral coated tablet formulations, including a high-potency 'FORTE' version containing 600 mg of extract per tablet, and is approved for use in adults and adolescents aged 12 years and older.

Brand names
CynarixCynarix FORTE
Other names
artichoke leaf dry extractCynara scolymus extract
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)GSK3 (Glycogen synthase kinase 3 beta)

Beyond the preview

Go deeper on Cynarix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cynarix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call